Login to Your Account

To Re-Submit In January

Raising $20M, Avanir Prepares New Neurodex Data For FDA

By Randall Osborne

Monday, December 19, 2005
Two months after disclosing a plan to raise $16.2 million in a stock offering, Avanir Pharmaceuticals Inc. said it's packing in another $20 million, having gained commitments from buyers of 6 million Class A shares at $3.35 each. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription